Gene · 8318
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging strategies for cancer therapy by ATR inhibitors. | Cancer Sci | 2023 | 37189251 | PubTator, text mining | PubMed |
| Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data. | Sci Rep | 2023 | 37188913 | PubTator, text mining | PubMed |
| Identification of GINS1 as a potential prognostic biomarker for sarcoma using bioinformatic analysis. | Transl Cancer Res | 2023 | 37180662 | PubTator, text mining | PubMed |
| Chromosome 22q11.2 Deletion Syndrome: A Comprehensive Review of Molecular Genetics in the Context of Multidisciplinary Clinical Approach. | Int J Mol Sci | 2023 | 37176024 | PubTator, text mining | PubMed |
| The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors. | Cells | 2023 | 37174744 | PubTator, text mining | PubMed |
| Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells. | J Neurooncol | 2023 | 37169948 | PubTator, text mining | PubMed |
| Replisome-cohesin interactions provided by the Tof1-Csm3 and Mrc1 cohesion establishment factors. | Chromosoma | 2023 | 37166686 | PubTator, text mining | PubMed |
| Profiling the bloodstream form and procyclic form Trypanosoma brucei cell cycle using single-cell transcriptomics. | Elife | 2023 | 37166108 | PubTator, text mining | PubMed |
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
| The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. | Biochem Soc Trans | 2023 | 37145026 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer. | Heliyon | 2023 | 37144199 | PubTator, text mining | PubMed |
| Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. | J Hepatocell Carcinoma | 2023 | 37128594 | PubTator, text mining | PubMed |
| Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis. | Proteins | 2023 | 37119038 | PubTator, text mining | PubMed |
| Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics. | Int J Mol Sci | 2023 | 37108690 | PubTator, text mining | PubMed |
| Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML. | Leukemia | 2023 | 37106163 | PubTator, text mining | PubMed |
| DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | Nat Commun | 2023 | 37105989 | PubTator, text mining | PubMed |
| RAD51 bypasses the CMG helicase to promote replication fork reversal. | Science | 2023 | 37104614 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer. | Front Oncol | 2023 | 37091166 | PubTator, text mining | PubMed |
| Gene dysregulation in acute HIV-1 infection - early transcriptomic analysis reveals the crucial biological functions affected. | Front Cell Infect Microbiol | 2023 | 37077524 | PubTator, text mining | PubMed |
| Cross-linking mass spectrometry discovers, evaluates, and corroborates structures and protein-protein interactions in the human cell. | Proc Natl Acad Sci U S A | 2023 | 37071682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8318/papers?page=11